# Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer Pain

> **NCT05962294** · — · UNKNOWN · sponsor: **Henan Cancer Hospital** · enrollment: 916 (estimated)

## Conditions studied

- Cancer Pain
- Real-world Study
- Oxycodone

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05962294
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 916 (ESTIMATED)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05962294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05962294, "Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer Pain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05962294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*